Erastin-induced multi-pathway cell death in endometriosis: a mechanistic and translational narrative review
Authors:
Open Access
- 10 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
Abstract
This narrative review examines the therapeutic potential of Erastin and its derivatives for endometriosis (EMS) by integrating mechanistic, preclinical, and translational perspectives. We conducted a focused review of literature from PubMed and Web of Science Core Collection (WoSCC) through August 2025; following a systematic screening and de-duplication process, 91 studies were included for synthesis. The evidence indicates that within the iron-rich, ROS-prone microenvironment of EMS, Erastin inhibits the system Xc− transporter, depletes intracellular glutathione (GSH), and inactivates GPX4, thereby driving ferroptosis in ectopic endometrial stromal cells. This process engages a coordinated network of regulated cell death that extends beyond ferroptosis to include crosstalk with necroptosis and pyroptosis, while being critically modulated by ferritinophagy and the paradoxical role of defective mitophagy. Despite the development of next-generation analogs with improved pharmacological properties, clinical translation is constrained by a narrow therapeutic window due to on-target and off-target toxicities. To overcome these limitations, we propose that future strategies must prioritize lesion-focused drug delivery, such as nanocarriers and triggerable prodrugs, alongside biomarker-guided treatment regimens to decouple efficacy from systemic risk, paving a credible path for the clinical application of Erastin-class agents in EMS.Keywords
This publication has 105 references indexed in Scilit:
- Sulfasalazine combined with anti-IL-1β mAb induces ferroptosis and immune modulation in oral squamous cell carcinomaCellular and Molecular Life Sciences, 2025
- Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer TherapyAngewandte Chemie International Edition, 2024
- Molecular mechanism of autophagy and apoptosis in endometriosis: Current understanding and future research directionsReproductive Medicine and Biology, 2024
- Prohibitin2/PHB2, Transcriptionally Regulated by GABPA, Inhibits Cell Growth via PRKN/Parkin-dependent Mitophagy in EndometriosisReproductive Sciences, 2023
- ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosisArchives of Toxicology, 2023
- Hormonal treatments for endometriosis: The endocrine backgroundReviews in Endocrine and Metabolic Disorders, 2021
- The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis2021
- CPEB1 enhances erastin‐induced ferroptosis in gastric cancer cells by suppressing twist1 expressionIUBMB Life, 2021
- System Xc−: a key regulatory target of ferroptosis in cancerInvestigational New Drugs, 2021
- Endometriosis: The Role of Iron Overload and FerroptosisReproductive Sciences, 2020